Study Shows Sandoz Biosimilar Equivalent to Originator Drug

News   Jul 12, 2016

 
Study Shows Sandoz Biosimilar Equivalent to Originator Drug
 
 
 

RELATED ARTICLES

Evolution Threatens Efficient Bioproduction Scale-Up

News

The transition towards sustainable biobased chemical production is important for green growth, but productivity and yield of engineered cells frequently decrease in large industry-scale fermentation. According to a new study, the role of evolution has been underestimated in limiting bioprocesses.

READ MORE

Studying Ebola-Host Cell Interaction Helps Find Targets for Antiviral Drugs

News

In some ways, the Ebola virus operates like a vampire; only after it is politely invited in to a host cell does it take up the task of destroying everything in its path. In a new study researchers seek to elucidate quantitatively the biomechanical mechanism of Ebola-host cell interaction, providing potential new targets for antiviral drug development.

READ MORE

Putting the Brain at the Center of Anesthesiology

News

Emery N. Brown explains how statistics and neuroscience improve anesthesiology at the American Association for the Advancement of Science's annual meeting.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE